Australia’s active vaccine safety system

Influenza vaccines

Vaccine safety data

AusVaxSafety commenced routine safety monitoring of 2024 seasonal influenza vaccines used in Australia across all ages in March 2024.

The influenza vaccines in use in Australia in 2024 are:

Standard influenza vaccines

  • Afluria® Quad (individuals aged 5 years and older)
  • Fluarix Tetra® (individuals aged 6 months and older)
  • Flucelvax® Quad (individuals aged 6 months and older)
  • FluQuadri® (individuals aged 6 months and older)
  • Influvac® Tetra (individuals aged 6 months and older)
  • Vaxigrip Tetra® (individuals aged 6 months and older).

Adjuvanted or high-dose vaccines

  • Fluad® Quad (individuals aged 65 years and over)
  • Fluzone® High-Dose Quad (individuals aged 60 years and over).

Surveillance data are gathered via AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination.
 


Latest influenza vaccine safety data

Click on the tiles below to view 2024 AusVaxSafety influenza vaccine safety data for specific age and population groups. Note: Additional age and population groups will be added below once enough data are collected for meaningful analysis.

Influenza vaccine safety data - 5 years and older (standard vaccines)

View the latest safety data here
Influenza vaccine safety data – 60 years and older (adjuvanted or high-dose vaccine)

View the latest safety data here
Vaccine safety data

News & events

All news & events

AusVaxSafety receives funding
from the Australian Government

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Copyright © 2022 AusVaxSafety. All rights reserved

vaccine

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.